4 studies found for:    cdc7
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated A Study of BMS-863233 in Patients With Hematologic Cancer
Condition: Refractory Hematologic Cancer
Intervention: Drug: Cdc7-inhibitor (BMS-863233)
2 Terminated A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Conditions: Advanced Solid Cancers;   Metastatic Cancer
Intervention: Drug: Cdc7-inhibitor
3 Terminated Study of NMS-1116354 in Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: NMS-1116354
4 Terminated Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
Condition: Advanced/Metastatic Solid Tumors
Intervention: Drug: NMS-1116354

Indicates status has not been verified in more than two years